Search results
3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing
InvestorPlace via Yahoo Finance· 1 year agoThe 2022 Nobel Prize in Chemistry went to Emmanuelle Charpentier and Jennifer Doudna for their work...
How Jennifer Doudna's Life Has Changed Since Discovering CRISPR 10 Years Ago
Time via Yahoo News· 2 years agoDr. Jennifer Doudna in Berkeley, Calif., on Jan. 18, 2019. Credit - Anastasiia Sapon—The New York...
Bull of the Day: CRISPR Therapeutics (CRSP)
Zacks via Yahoo Finance· 4 months agoCRISPR Therapeutics (CRSP) just made history on Friday with the first FDA-approved gene-editing medicine based on the Nobel Prize-winning discovery that...
FDA Approves First CRISPR Treatment in U.S.
Time via Yahoo News· 4 months agoSickled blood cells forming clumps in a vessel Credit - Getty Images It was only 11 years ago that scientists Jennifer Doudna and Emmanuelle Charpentier...
Editas cashes in on CRISPR patent with Vertex deal
BioPharma Dive via Yahoo Finance· 4 months agoDive Brief: Days after winning U.S. approval of the first CRISPR gene-editing medicine, Vertex Pharmaceuticals is clearing up potential intellectual...
Guest column: Why new DNA research changes how scientists study disease
The Oklahoman via Yahoo News· 1 year agoThe year is at a stage where it’s pretty much all possibility. Sure, a resolution or two may have...
CRISPR 'will provide cures for genetic diseases that were incurable before,' says renowned...
Live Science via Yahoo News· 2 months agoVirginijus Šikšnys (an older man with short brown hair and round glasses wearing a suit jacket)...
The FDA just approved the first gene editing therapy for sickle cell anemia, but it'll cost $2.2...
Business Insider via Yahoo News· 4 months agoThe FDA approved the first gene therapy for sickle cell anemia.Meletios Verras/ iStock The FDA...
What's Next For Gene-Editing Darling Crispr After Its 'Historic' First-Ever Approval?
Investor's Business Daily· 5 months agoCrispr Therapeutics just executed on a moonshot goal as it recently won U.K. approval for the first...
After a decade, CRISPR gene editing is a 'revolution in progress.' What does the future hold?
USA TODAY via Yahoo News· 1 year agoMedical innovations typically take 17 years from the time a lightbulb goes off in a scientist's head...
